Characterization of lamina propria FOXP3+ cells
. | HIV-infected patients . | . | . | . | |
|---|---|---|---|---|---|
. | Naive . | Treated . | Norovirus . | Control . | |
| No. patients | 11 | 9 | 6 | 12 | |
| CD25* | 96 ± 7 | 97 ± 9 | 97 ± 4 | 96 ± 22 | |
| CTLA-4* | 64 ± 8 | 59 ± 7 | 70 ± 47 | 89 ± 19 | |
| GITR* | 77 ± 10 | 75 ± 17 | 87 ± 7 | 89 ± 19 | |
. | HIV-infected patients . | . | . | . | |
|---|---|---|---|---|---|
. | Naive . | Treated . | Norovirus . | Control . | |
| No. patients | 11 | 9 | 6 | 12 | |
| CD25* | 96 ± 7 | 97 ± 9 | 97 ± 4 | 96 ± 22 | |
| CTLA-4* | 64 ± 8 | 59 ± 7 | 70 ± 47 | 89 ± 19 | |
| GITR* | 77 ± 10 | 75 ± 17 | 87 ± 7 | 89 ± 19 | |
Paraffin sections from duodenum were stained with the respective markers.
Values are mean percentages ± SD of lamina propria FOXP3+ mononuclear cells coexpressing the indicated marker. Values are 100 for CD3 and 0 for CD8, HLA-DR, and CD38.